Initiation or switch to insulin degludec/insulin aspart in adults with type 2 diabetes in India: Results from a prospective, non-interventional, real-world study.

Autor: Baruah MP; Department of Endocrinology, Apollo Excelcare Hospital, Guwahati, Assam, India., Aneja P; Department of Diabetes and Metabolic Diseases, Max Hospital, New Delhi, India., Pitale S; Department of Endocrinology, Dew Medicare and Trinity Hospital, Nagpur, Maharashtra, India., Bhograj A; Department of Endocrinology, Columbia Asia Hospital, Bengaluru, Karnataka, India., Agrawala RK; Department of Diabetology and Endocrinology, AMRI Hospital, Bhubaneswar, Odisha, India., Aggarwal A; Department of Endocrinology, Fortis Hospital, New Delhi, India., Mahadev PG; Department of Diabetology, Pranav Diabetes Center and Pace Clinical Research, Bengaluru, Karnataka, India., Madhavdas DC; Department of Diabetology, RM Education Research Foundation, Chennai, Tamil Nadu, India., Shah S; Department of Diabetology and Endocrinology, Narayana Superspeciality Hospital, Kolkata, West Bengal, India., John M; Department of Endocrinology, Providence Endocrine and Diabetes Specialty Centre, Thiruvananthapuram, Kerala, India., Pathan MKA; Department of Clinical, Medical and Regulatory, Novo Nordisk India Private Limited, Bengaluru, Karnataka, India., Revanna M; Department of Global Medical Affairs, Novo Nordisk A/S, Copenhagen, Denmark., Chandrappa M; Department of Clinical, Medical and Regulatory, Novo Nordisk India Private Limited, Bengaluru, Karnataka, India., Singh KP; Department of Endocrinology, Fortis Hospital, Mohali, Punjab, India.

Publikováno v: Journal of family medicine and primary care [J Family Med Prim Care] 2024 Sep; Vol. 13 (9), pp. 3590-3597. Date of Electronic Publication: 2024 Sep 11.